Added to YB: 2024-02-02
Pitch date: 2024-02-01
QURE [bullish]
uniQure N.V.
+660.18%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases in the United States.
Market Cap
$2.9B
Pitch Price
$5.50
Price Target
32.90 (-21%)
Dividend
N/A
EV/EBITDA
-16.83
P/E
-11.99
EV/Sales
156.62
Sector
Biotechnology
Category
value
Show full summary:
uniQure: The Valuation Got More Attractive
QURE: Undervalued at $5.8 vs. $32.9 fair value post royalty sale validating assumptions, restructuring saving $180M, and IND approvals. Monte Carlo shows $26-$35 range. Downside risks remain, but 5x return potential. Increased long position.
Read full article (7 min)